Estrogen Receptor-α Agonists Promote Angiogenesis in Human Myometrial Microvascular Endothelial Cells

Abstract

Objective: The relative role of the two estrogen receptors, ERα and ERβ, in mediating angiogenic responses in adult human endothelium is unknown. The aim of this study was to determine whether novel ERα-selective agonists, propyl pyrazole triol (PPT) and the tetrahydrochrysene (R,R-THC), up-regulate the expression of vascular endothelial growth factor receptor-2 (VEGFR-2),and promote VEGF-stimulated endothelial cell proliferation in primary cultures of adult female microvascular endothelial cells so-expressing endogenous ERα and ERβ.

Methods: Confluent primary cultures of microvascular endothelial cells isolated from human myometrium were incubated with 17β-estradiol (1 and 10 nM), PPT (10 nM to 3 μM), or R,R-THC (10 nM to 3 μM) for 18 hours and VEGFR-2 expression measured by biotin-VEGF₁₆₅ binding and flow cytometry. Endothelial cell proliferation was assessed in microvascular endothelial cells after incubation with 17β-estradiol (10 nM), PPT (100 nM), and R,R-THC (100 nM) for 6 days using a tetrazolium-based bioassay.

Results: Both PPT and R,R-THC increased VEGFR-2 expression on myometrial microvascular endothelial cells in a dose-dependent manner, reaching a maximum at 1 μM. Approximately 40% of myometrial microvascular endothelial cell isolates only express ERβ and do not express ERα, and in these neither PPT, R,R-THC, nor 17β-estradiol increased VEGF binding. PPT- or R,R-THC-stimulated increase in VEGF binding was significantly different between ERα⁺ and ERα^- microvascular endothelial cell samples (P < .001 and P < .05, respectively). PPT, R,R-THC, and 17β-estradiol significantly augmented VEGF-stimulated microvascular endothelial cell proliferation in ERα⁺ (P < .05), but not in ERα^- samples.

Conclusions: This angiogenic effect of 17β-estradiol on adult female microvascular endothelial cells is mediated by ERα, rather than ERβ.

Keywords

ERα ERα agonists angiogenesis human microvascular endothelial cells VEGF receptors myometrium

Get full access to this article

View all access options for this article.

References

1. Folkman J , Shing Y . Angiogenesis. J Biol Chem 1992;267:10931-10934.

2. Losordo DW , Isner JM . Estrogen and angiogenesis-A review. Arterioscler Thromb Vasc Biol 2001;21:6-12.

3. Manson JE , Hsia J , Johnson KC , et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523-534.

4. Ferrara N , Gerber HP , LeCouter J . The biology of VEGF and its receptors. Nat Med 2003;9:669-676.

5. Gargett CE , Weston G , Rogers PAW . Mechanisms and regulation of endometrial angiogenesis. Reprod Med Rev 2002;10:45-61.

6. Kremer C , Breier G , Risau W , Plate KH . Up-regulation of flk-1/vascular endothelial growth factor receptor 2 by its ligand in a cerebral slice culture system. Cancer Res 1997;57:3852-3859.

7. Spyridopoulos I , Sullivan AB , Kearney M , Isner JM , Losordo DW . Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis: Estradiol as a survival factor. Circulation 1997;95:1505-1514.

8. Razandi M , Pedram A , Levin ER . Estrogen signals to the preservation of endothelial cell form and function. J Biol Chem 2000;275:38540-38546.

9. Suzuma I , Manadi M , Takagi H , et al. 17 β-Estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 1999;40:2122-2129.

10.

10. Gargett CE , Zaitseva M , Bucak K , Chu S , Fuller PJ , Rogers PAW . 17β-Estradiol up-regulates vascular endothelial growth factor receptor-2 expression in human myometrial microvascular endothelial cells: Role of estrogen receptor-α and -β. J Clin Endocrinol Metab 2002;87:4341-4349.

11.

11. Jesmin S , Hattori Y , Sakuma I , Liu MY , Mowa CN , Kitabatake A . Estrogen deprivation and replacement modulate cerebral capillary density with vascular expression of angiogenic molecules in middle-aged female rats. J Cereb Blood Flow Metab 2003;23:181-189.

12.

12. Mendelsohn ME , Karas RH . The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801-1811.

13.

13. Johns A , Freay AD , Fraser W , Korach KS , Rubanyi GM . Disruption of estrogen receptor gene prevents 17β estradiol-induced angiogenesis in transgenic mice. Endocrinology 1996;137:4511-4513.

14.

14. Brouchet L , Krust A , Dupont S , Chambon P , Bayard F , Arnal JF . Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-β. Circulation 2001;103:423-428.

15.

15. Zhu Y , Bian Z , Lu P , et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science 2002;295:505-508.

16.

16. Pare G , Krust A , Karas RH , et al. Estrogen receptor-α mediates the protective effects of estrogen against vascular injury. Circ Res 2002;90:1087-1092.

17.

17. Karas RH , Schulten H , Pare G , et al. Effects of estrogen on the vascular injury response in estrogen receptor α, β (double) knockout mice. Circ Res 2001;89:534-539.

18.

18. Stauffer SR , Coletta CJ , Tedesco R , et al. Pyrazole ligands: Structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 2000;43:4934-4947.

19.

19. Harrington WR , Sheng SB , Barnett DH , Petz LN , Katzenellenbogen JA , Katzenellenbogen BS . Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 2003;206:13-22.

20.

20. Harris HA , Katzenellenbogen JA , Katzenellenbogen BS . Characterization of the biological roles of the estrogen receptors. ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology 2002;143:4172-4177.

21.

21. Frasor J , Barnett DH , Danes JM , Hess R , Parlow AF , Katzenellenbogen BS . Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) α activity by ERβ in the uterus. Endocrinology 2003;144:3159-3166.

22.

22. Meyers MJ , Sun J , Carlson KE , Katzenellenbogen BS , Katzenellenbogen JA . Estrogen receptor subtype-selective ligands: Asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl-5,6,11,12-tetrahydrochrysenes. J Med Chem 1999;42:2456-2468.

23.

23. Sun J , Meyers MJ , Fink BE , Rajendran R , Katzenellenbogen JA , Katzenellenbogen BS . Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-α or estrogen receptor-β. Endocrinology 1999;140:800-804.

24.

24. Chambliss KL , Yuhanna IS , Anderson RGW , Mendelsohn ME , Shaul PW . ERβ has nongenomic action in caveolae. Mol Endocrinol 2002;16:938-946.

25.

25. Nuedling S , Karas RH , Mendelsohn ME , et al. Activation of estrogen receptor β is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett 2001;502:103-108.

26.

26. Gargett CE , Bucak K , Rogers PAW . Isolation, characterization and long-term culture of human myometrial microvascular endothelial cells. Hum Reprod 2000;15:293-301.

27.

27. Vladusic EA , Hornby AE , Guerra-Vladusic FK , Lakins J , Lupu R . Expression and regulation of estrogen receptor β in human breast tumors and cell lines. Oncol Rep 2000;7:157-167.

28.

28. Gargett CE , Bucak K , Zaitseva M , et al. Estrogen receptor-α and -β expression in microvascular endothelial cells and smooth muscle cells of myometrium and leiomyoma. Mol Hum Reprod 2002;8:770-775.

29.

29. Kim-Schulze S , McGowan KA , Hubchak SC , et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996;94:1402-1407.

30.

30. Garlanda C , Dejana E . Heterogeneity of endothelial cells-Specific markers. Arterioscler Thromb Vasc Biol 1997;17:1193-1202.

31.

31. Pendaries C , Darblade B , Rochaix P , et al. The AF-1 activation-function of ERα may be dispensible to mediate the effect of estradiol on endothelial NO production in mice. Proc Natl Acad Sci U S A 2002;99:2205-2210.

32.

32. Katzenellenbogen BS , Choi IH , Delage-Mourroux R , et al. Molecular mechanisms of estrogen action: Selective ligands and receptor pharmacology. J Steroid Biochem Mol Biol 2000;74:279-285.